Navigation Links
Abbott's HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
Date:9/27/2007

Prix Galien USA Names HUMIRA Best Biotechnology Product

ABBOTT PARK, Ill., Sept. 27 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT), a leader in the treatment of autoimmune diseases, has received the 2007 Galen Prize for Best Biotechnology Product for HUMIRA (R) (adalimumab), the first approved fully human antibody. HUMIRA is approved for use in the treatment of moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and moderate to severe Crohn's disease. The Galen Prize, considered an equivalent to the Nobel Prize and awarded by Prix Galien USA, is one of the highest accolades in the pharmaceutical and biomedical industry recognizing excellence in medical and scientific research and innovation.

This is the first year in which the award, founded in France in 1970 and recognized as an international research honor, has been expanded to recognize scientific innovation from U.S. pharmaceutical and biotechnology companies specifically. Abbott won the prestigious Prix Galien international award in 1999 for developing one of the first protease inhibitors for the treatment of HIV.

"Abbott is extremely honored to be a Galen Prize recipient, as it recognizes our diligence in the discovery and development of innovative treatments for immunologic diseases," said John Leonard, M.D., vice president, Global Medical and Scientific Affairs, Abbott. "HUMIRA has become an important treatment option for many patients dealing with these diseases."

HUMIRA resembles antibodies normally found in the body and works by specifically blocking tumor necrosis factor alpha (TNF-alpha), a protein that when produced in excess, plays a central role in the inflammation associated with autoimmune diseases. HUMIRA is a fully-human self-administered biologic and 190,000 patients worldwide are currently being treated.

"HUMIRA represents years of dedicated research as part of our commitment to improve the human condition," said Jochen
'/>"/>

SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Abbotts Humira(r) (Adalimumab) Gets Approval by EU for Crohns Disease Treatment
2. Doctor of Indian Origin Honored by California
3. Florence Nightingales of India Honored by President
4. Sex Offender Honored Twice by Texan Lawmakers
5. 42-year-old Cancer Patient Honored by British Queen for Her Fundraising Efforts
6. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
7. Prestigious Gairdner Awards for medical research in 2006 Goes To Two Yale biologists
8. Rice University wins Prestigious Grants from HHMI
9. Developer Of Vaccine For Cancer Granted A Prestigious Fellowship
10. Indian Americans Compete for the Prestigious Spelling Bee Contest
11. Prestigious Wilson Award Goes To Yale Cell Biologist Joel Rosenbaum

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , NEW YORK, Nov. 30 Repo...report is available in its catalogue: ,, The F...gic issues and targeted opportunities for older co...51/The-Future-of-Senior-Nutrition-Key-ingredients-...der-consumers.html ,, Seniors, have emerged as...
(Date:11/30/2009)... , DEL MAR, Calif., Nov. 30 /PRNewswire-Firs...n (Pink Sheets: ADHC) is pleased to announce the a...dent director to the Company,s Board of Directors....r a 40 year period starting at the Chemical Bank i...r of Harris, Bretall & McEldowney, San Francis...
(Date:11/30/2009)... , CHICAGO, Nov. 30 Physicians ...eported today on results of a study demonstrating ...T angiography (cCTA) by Rcadia,s COR Analyzer Syst...artery stenosis in hospital emergency department (...automated system to enhance the use of cCTA has po...
(Date:11/30/2009)...N, NY When asked to inhibit their response to a "...on average, able to suppress activity in brain reg...udy at the U.S. Department of Energy,s Brookhaven ...in an upcoming issue of NeuroImage , suggest that...se inhibitory responses could help cocaine abusers...
(Date:11/30/2009)...alcoholics tend to drink heavily more often than y... Nov. 30 (HealthDay News) -- Older people who are ...ounger counterparts, a new report finds, possibly ... effect. , According to a study released this ...han 60 consume more than 40 drinks a week, on aver...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 2Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 3Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 4Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 5Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 6Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 7Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 8Health News:American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3Health News:Brain scan study shows cocaine abusers can control cravings 2Health News:Brain scan study shows cocaine abusers can control cravings 3Health News:Binge Drinking Not Just a Rite of the Young 2
...gestions to help with s...r vacations are in full,swing and travelers are pa...big question is what should they bring to help wit... "Homeopathic products are great for everyone; pa...
...termine how they decide to control their own figur...ey from the Children,s National Medical Center in ...eca from the University of Miami. Also influencing... have just been published online in the Journal o...
...International,Liquidity, SYDNEY, Australia and BE...X), a clinical-stage specialty pharmaceutical,comp...on of therapies for,pain and central nervous syste.... QRxPharma,s ADR began trading,yesterday, June 30...
...acles -- a 30-minute public affairs television pro...tories of real patients -- will feature,four-time ...uly 6, the,program will debut in Los Angeles on KC...rldwide in 1984,when he won the Gold Medal at the ...
... is the premier sponsor of the 3rd Annual World Co... two-day event, held in Boston, MA on July,22-23, ...ge (HIE) to the,next level., Accenx is the leadin...king scalable strategies for exchanging,actionable...
...lth policy and administration in Penn State,s Coll...ded a three-year, $4 million grant from the Robert...ation of a RWJF national initiative, "Aligning For... scope of the project. "AF4Q" aims to bring togeth...
Other Medicine News:Health News:Homeopathic First Aid Kit: Solutions for Summer's Little Bummers 2Health News:Homeopathic First Aid Kit: Solutions for Summer's Little Bummers 3Health News:Does this make me look fat? 2Health News:QRxPharma Begins Trading on the International OTCQX 2Health News:QRxPharma Begins Trading on the International OTCQX 3Health News:QRxPharma Begins Trading on the International OTCQX 4Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 2Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 3Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 4Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 5Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 6Health News:Accenx Technologies, a Premier Sponsor as the Educational Underwriters of the 3rd Annual World Congress Leadership Summit on The Road to Interoperability 2Health News:Researcher receives $4 million from RWJ Foundation to study health quality reform project 2
(Date:11/30/2009)...30 Dr. Jocelyn Rapelyea, Associate...orge Washington University Medical Center in Washi...ified with Breast-Specific Gamma Imaging (BSGI) ca...r needle biopsy as well, as for pre-operative loca...ogical Society of North America (RSNA). ,, BSGI...
(Date:11/30/2009)...Nov. 30 Minimally-invasive procedu...rgery, particularly in oncology, cardiology and wo...or image-guided navigation expected to reach $600 ...ntages offered by minimally-invasive procedures, i...atient comfort and faster patient throughput. ,...
(Date:11/30/2009)...IV, Israel, November 30 Optoacoust...) dual channel microphone, the most advanced,optic...etic resonance imaging,(fMRI) environments. ,... step forward for fiber,optic microphone technolog...h,low-latency adaptive noise cancelling. The FOMRI...
Breaking Medicine Technology:Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2Killer bees may increase food supplies for native bees 10219 1Killer bees may increase food supplies for native bees 10219 2InVitria 26apos 3Bs Better Ingredients for Better Media to be Showcased at BPI 26apos 3B09 58682 1InVitria 26apos 3Bs Better Ingredients for Better Media to be Showcased at BPI 26apos 3B09 58682 2Maryland Residents Participate in Launch of National Video Campaign 3A Say Yes to Health Reform 58678 1Maryland Residents Participate in Launch of National Video Campaign 3A Say Yes to Health Reform 58678 2Maryland Residents Participate in Launch of National Video Campaign 3A Say Yes to Health Reform 58678 3
...ears of Treatment Presented at ICAAC/IDSA,2008 Ann...,Corporation (NYSE: SGP ) today reported a data a...al CCR5 receptor antagonist, demonstrated,sustaine...and was well,tolerated through up to four years of...ients. Vicriviroc was administered once-daily as a...
...udies affirmed the clinical benefits of,ACTEMRA -,...tudies,showed that patients who suffer from the de...itis (RA) achieved significant improvements in sig...lizumab) alone or in combination,with methotrexate...ts of,both studies will be presented as oral prese...
Other Medicine Technology:Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 2Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 3Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 4Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 5Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 6ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 2ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 3ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 4ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 5ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 6
Power Supply EV265 for electrophoresis, 115V
EPS 601 Power Supply
...ly . The digital 200 V/2000 mA PSE Power Supply p...ts. • It is possible to run up to three SEA 2...atures: Direct reading of programmed preset and ac...ltage, mA and timer adjustable during a run •...
PowerPac HV Power Supply With Temperature Probe
Medicine Products: